Skip to content

Feasibility study of an ambulatory closed-loop system for the automated control of blood glucose with remote monitoring in type 1 diabetes (The Diabetes Assistant) - DiAs Trial

Feasibility study of an ambulatory closed-loop system for the automated control of blood glucose with remote monitoring in type 1 diabetes (The Diabetes Assistant) - DiAs Trial - DiAs Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39284
Enrollment
8
Registered
2012-05-04
Start date
2012-11-25
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

This pilot study entails a hotel design targeting adults with T1D that are experienced insulin pump users. Subjects will spend two nights in a local hotel, during which the phone-based system will b

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: aged 21 years or older Diagnosed with type 1 diabetes mellitus use of an insulin pump for at least 1 year HbA1c between 6.0% and 9.0%

Exclusion criteria

Exclusion criteria: Diabetic Ketoacidosis within the last 6 months Severe hypoglycaemia within the last 12 months Pregnancy

Design outcomes

Secondary

MeasureTime frame
Secondary endpoints include the failure rates of system components, frequency of lost or inaccurate CGM records, and percent time of active CTR. The failure/missing data records will be compared to failure/missing data records from our past in-clinic studies.

Primary

MeasureTime frame
The main endpoint will be the percent time the system is operative with all expected data from CGM, pump and patient manual inputs available on the Artificial Pancreas platform and monitoring stations. To be considered as successful, this percent time will have to reach more than 80% of total time of investigation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)